Cas:7541-30-2 N-[2-Hydroxy-5-(1-hydroxy-2-{[2-(4-methoxyphenyl)ethyl]amino}prop yl)phenyl]methanesulfonamide manufacturer & supplier

Chemical Name:N-[2-Hydroxy-5-(1-hydroxy-2-{[2-(4-methoxyphenyl)ethyl]amino}prop yl)phenyl]methanesulfonamide

CAS.NO:7541-30-2

Synonyms:N-[2-Hydroxy-5-(1-hydroxy-2-{[2-(4-methoxyphenyl)ethyl]amino}prop yl)phenyl]methanesulfonamide

Molecular Formula:C₁₉H₂₆N₂O₅S

Molecular Weight:394.48500

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:600.7ºC at 760 mmHg

Density:1.302g/cm3

Index of Refraction:1.608

PSA:116.27000

Exact Mass:394.15600

LogP:3.57120

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like N-[2-Hydroxy-5-(1-hydroxy-2-{[2-(4-methoxyphenyl)ethyl]amino}prop yl)phenyl]methanesulfonamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-[2-Hydroxy-5-(1-hydroxy-2-{[2-(4-methoxyphenyl)ethyl]amino}prop yl)phenyl]methanesulfonamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-[2-Hydroxy-5-(1-hydroxy-2-{[2-(4-methoxyphenyl)ethyl]amino}prop yl)phenyl]methanesulfonamide Use and application,N-[2-Hydroxy-5-(1-hydroxy-2-{[2-(4-methoxyphenyl)ethyl]amino}prop yl)phenyl]methanesulfonamide technical grade,usp/ep/jp grade.

Related News: Overall, Wang confirmed that AZ can still grow its China business at low double digits in the second half of the year, but the company declined to offer an outlook for 2022. 2,4-Imidazolidinedione, 5-hexyl-1,3-dimethyl-, (S)- manufacturers The Company has run a comprehensive range of specialized in vitro and in vivo tests on its patent-pending novel compounds to select the optimal psychedelic drug candidate for progressing towards human clinical trials. 2-methyl-1-(p-hydroxymethylbenzoyl)-1,2,3,4-tetrahydroquinoline suppliers The suit says that while BRAF kinase inhibitors existed prior to Plexxikon’s discoveries, they were not selective, and Plexxikon’s have a core molecular structure that allows them to bind selectively to kinase created by the BRAF mutation. That allows for higher doses to be administered. 1-(3-(4-((2,3-dihydrobenzo[b][1,4]dioxin-2-yl)methyl)piperazin-1-yl)-4-methoxyphenyl)-3-(3,4-dimethylphenyl)urea dihydrochloride vendor & factory.